Intelligence · Clinical pipeline
Metabolic & obesity · Approved programs
Metabolic & obesity programs at Approved programs — ClinicalTrials.gov pipeline intelligence.
Quick answer
Metabolic & obesity Approved programs programs: NovaPharmaNews indexes 105 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- Takeda 21 programs
- First People's Hospital 15 programs
- Disc Medicine 7 programs
- Regeneron UK 7 programs
- George Institute for 5 programs
- Chinese Academy of 4 programs
- Hospital Authority 4 programs
- Sanofi Pasteur MSD 4 programs
- ANI PHARMACEUTICALS 3 programs
- Eli Lilly and 3 programs
- HALOZYME THERAPEUTICS 3 programs
- NovoThirteen 3 programs
Pipeline programs
-
Metformin
Takeda
Type 2 Diabetes Mellitus
1 trial -
Mounjaro solution for injection in pre-filled... for Obesity
The George Institute
Obesity
1 trial -
Mysimba 8 mg/90 mg prolonged-release tablets
Disc Medicine
Obesity, Obesity Surgery
1 trial -
NESINA ACT TAB. 25/15mg
Takeda
Diabetes
1 trial -
NN1436-7727
NovoThirteen
Type 2 diabetes
1 trial -
NN9536-7752
NovoThirteen
Obesity
1 trial -
NN9838-4968
NovoThirteen
Obesity and T2D
1 trial -
Nocardia rubra Cell Wall Skeleton
The First People's Hospital of Lianyungang
Diabetic Foot Ulcer
1 trial -
Optimal hypoglycemic treatment
The First People's Hospital of Lianyungang
Type2 Diabetes
1 trial -
PI24/01356
The George Institute
Type 2 diabetes
1 trial -
Pharmacotherapy
The First People's Hospital of Lianyungang
Diabetes Mellitus, Type 2
1 trial -
Pioglitazone
Takeda
Diabetes Mellitus
9 trials -
Pioglitazone
Takeda
Diabetes Mellitus, Type 2
2 trials -
Pioglitazone
Takeda
Diabetes Type 2
1 trial -
Pioglitazone
Takeda
Metabolic Syndrome
1 trial -
Pioglitazone
Takeda
Obesity
1 trial -
Pioglitazone
Takeda
Type II Diabetes Mellitus
1 trial -
Pioglitazone and Metformin
Disc Medicine
Diabetes Mellitus, Type 2
1 trial -
Pioglitazone and insulin
Takeda
Diabetes Mellitus
2 trials -
Pioglitazone and metformin
Takeda
Diabetes Mellitus
5 trials -
Pioglitazone then Placebo
Takeda
Diabetes
1 trial -
Placebo of vildagliptin
Novartis Pharmaceuticals
Type 2 Diabetes Mellitus
1 trial -
Plasma rich in growth factors
Wuhan Createrna Science and Technology Co., Ltd
Foot ulcers in diabetic patients with peripheral arterial disease
1 trial -
Pregabalin
Yung NA
Diabetic Peripheral Neuropathy
1 trial -
R0126321A
Disc Medicine
Diabetic foot ulcer
1 trial -
RIMEGEPANT , Capsaicin
Disc Medicine
Obesity, Migraine
1 trial -
Rapid Acting insulin with pre-treatment of rHuPH20
HALOZYME THERAPEUTICS, INC.
Type 1 Diabetes Mellitus
1 trial -
Renin-angiotensin system blockers
Hospital Authority, Hong Kong
Diabetes
1 trial -
SGLT2 inhibitor
The First People's Hospital of Lianyungang
Type2 Diabetes
1 trial -
SGLT2 inhibitor (Empagliflozin 25 MG)
Hospital Authority, Hong Kong
Type2 Diabetes
1 trial -
SIMA SPK 01
The George Institute
End-stage kidney disease in Type 1 diabetes, SIROLIMUS VERSUS MYCOPHENOLATE MOFETIL IN SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANTATION TO EVALUATE THE RISK OF HERNIA
1 trial -
Semaglutide
United Therapeutics Europe Ltd
Obesity
1 trial -
Semaglutide B 3.0 mg/ml PDS290
Disc Medicine
obesity
1 trial -
Sham Injection
HALOZYME THERAPEUTICS, INC.
Type 1 Diabetes Mellitus
1 trial -
Simvastatin
Hospital Authority, Hong Kong
Obesity
1 trial -
Sitagliptin
Chen Suning
Type 2 Diabetes
1 trial -
Subcutaneous glargine insulin
Lxo Ireland Designated Activity Company
Diabetes Mellitus
1 trial -
TRS-2019-00002051
Wuhan Createrna Science and Technology Co., Ltd
Type 2 diabetes mellitus
1 trial -
Tirzepatide
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus
1 trial -
Toujeo
Almirall, S.A.
Diabetes Mellitus, Type 2
1 trial -
Trelagliptin
Takeda
Type 2 Diabetes Mellitus
2 trials -
Trelagliptin
Takeda
Type 2 Diabetes
1 trial -
Triple combination therapy group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 2 Diabetes Mellitus
1 trial -
Vortioxetine
Takeda
Type2 Diabetes
1 trial -
aflibercept 2.0 mg
Regeneron UK Limited
Diabetic Macular Edema
1 trial -
alogliptin+pioglitazone
Takeda
Diabetes Mellitus, Type 2
1 trial -
biphasic insulin aspart 30
Novo Nordisk A/S
Diabetes
2 trials -
dapagliflozin
The First People's Hospital of Lianyungang
Diabetic Kidney Disease
1 trial
Frequently asked questions
How many metabolic & obesity Approved programs programs exist?
105 programs match both the therapeutic area and stage filters in our published index.